Major Innovations from EDAP TMS at AUA Annual Meeting
EDAP TMS SA, a global pioneer in robotic energy-based therapies, is set to unveil its latest advancement, the Focal One i system, at the prestigious American Urological Association (AUA) Annual Meeting. This unveiling is eagerly anticipated and promises to showcase significant enhancements in prostate therapy technology.
Focal One i System: Key Features
The Focal One i consolidates its reputation for patient-specific imaging with the introduction of compatibility with PSMA PET scans and ExactVu Micro-Ultrasound. It also employs cutting-edge AI algorithms, like Unfold AI and OnQ Prostate, to elevate patient care and surgical accuracy.
Enhanced Integration with Imaging Technologies
This new system enhances its HIFUsion capabilities, seamlessly integrating 3D biopsy maps from Koelis and utilizing DynaCAD Urology datasets. Such integration is essential as it offers surgeons a comprehensive toolkit for personalized patient treatment.
Streamlined Treatment Workflows
The streamlined workflows introduced by the Focal One i ensure guided, step-by-step procedures that significantly boost efficiency during treatment sessions. This not only expedites workflow but also aids surgeons in maintaining focus on patient safety and successful outcomes.
Future Potential of Focal One i
One of the most exciting aspects of the Focal One i system is its potential for future capabilities, including treatment streaming and remote collaborative procedures. This hinges on an advanced digital interface that the company believes will revolutionize surgical training and mentorship.
Remote Proctoring and Collaboration
Remote proctoring stands out as a particularly transformative feature, allowing leading surgeons to assist others across the globe. A notable example includes the Cleveland Clinic's groundbreaking achievement of conducting a remote transatlantic Focal One Robotic HIFU treatment.
A Commitment to Innovation
EDAP TMS is devoted to ongoing innovation, showcasing its latest technology at cutting-edge surgical conferences. Attendees at the AUA meeting can experience a hands-on demonstration at booth #1419, allowing them to explore the new system's features and design enhancements firsthand.
About EDAP TMS SA
EDAP TMS has established itself as a leader in developing robotic energy-based therapies. The company specializes in manufacturing and distributing minimally invasive medical devices globally, employing ultrasound technology to treat a variety of medical conditions. With the Focal One system, EDAP TMS marks its prominence in prostate focal therapy managed by urologists, with potential applications extending well beyond prostate cancer.
Frequently Asked Questions
What is the Focal One i system?
The Focal One i system is an advanced robotic system designed for prostate therapy, integrating numerous imaging technologies and AI algorithms for optimal treatment planning.
What new features does the Focal One i offer?
It features improved imaging capabilities, streamlined workflows, remote proctoring, and is designed to enhance both efficiency and safety in surgical procedures.
How does EDAP TMS ensure the system meets surgeon needs?
EDAP TMS incorporates direct feedback from surgeons, ensuring that the system addresses the evolving challenges and needs within the medical field.
Where can I see a demonstration of the Focal One i?
You can experience a hands-on demonstration at the AUA Annual Meeting at booth #1419, where EDAP TMS will showcase the system.
Who can I contact for more information about EDAP TMS?
For inquiries, you can reach out to Blandine Confort, Investor Relations at EDAP TMS SA at +33 4 72 15 31 50 or via email at bconfort@edap-tms.com.
